Patents by Inventor Ruth BEN YAKAR

Ruth BEN YAKAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND REGIMENS FOR THE TREATMENT OF HEMATOLOGICAL CANCER
    Publication number: 20230158055
    Abstract: The invention provides methods and uses for the treatment of hematological cancer in a subject in need thereof.
    Type: Application
    Filed: April 22, 2021
    Publication date: May 25, 2023
    Applicant: Biosight Ltd.
    Inventors: Liat FLAISHON, Ruth BEN YAKAR
  • CYTARABINE CONJUGATES FOR CANCER THERAPY
    Publication number: 20210338704
    Abstract: The present invention relates to conjugates comprising cytarabine and an amino acid for use in the treatment of cancer. In particular, the present invention relates to conjugates of cytarabine and aspartic acid for use in the treatment of hematological cancers.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 4, 2021
    Applicant: Biosight Ltd.
    Inventors: Stela GENGRINOVITCH, Ruth Ben Yakar
  • Cytarabine conjugates for cancer therapy
    Patent number: 11058701
    Abstract: Provided relates to conjugates including cytarabine and an amino acid for use in the treatment of cancer. Further, the subject matter relates to conjugates of cytarabine and aspartic acid for use in the treatment of hematological cancers in medically compromised patients.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: July 13, 2021
    Assignee: Biosight Ltd.
    Inventors: Stela Gengrinovitch, Ruth Ben Yakar
  • COMBINATION CANCER THERAPY
    Publication number: 20200147117
    Abstract: The present invention relates to combination therapies of a cytarabine conjugate and one or more anti-neoplastic agents for inhibiting cancer cell growth. In particular, the present invention relates to a conjugate of cytarabine and aspartic acid (BST-236) in combination with one or more additional anti-neoplastic agents for use in the treatment of hematological cancers.
    Type: Application
    Filed: January 9, 2020
    Publication date: May 14, 2020
    Applicant: BIOSIGHT LTD.
    Inventors: Ruth BEN YAKAR, Stela Gengrinovitch, Shoshi Tessler, Liat Flaishon
  • CYTARABINE CONJUGATES FOR CANCER THERAPY
    Publication number: 20180369265
    Abstract: Provided relates to conjugates including cytarabine and an amino acid for use in the treatment of cancer. Further, the subject matter relates to conjugates of cytarabine and aspartic acid for use in the treatment of hematological cancers in medically compromised patients.
    Type: Application
    Filed: January 25, 2016
    Publication date: December 27, 2018
    Applicant: BIOSIGHT LTD.
    Inventors: Stela GENGRINOVITCH, Ruth BEN YAKAR